Approximately 5% to 10% of breast cancer cases and 11% to 18% of ovarian cancer cases are a result of a mutation in the BRCA1 and BRCA2 genes, known as hereditary breast and ovarian cancer (HBOC). The gene discussed is BRCA2; the disease is hereditary breast ovarian cancer syndrome.